GE launches $250M equity fund for healthcare tech firms

Justine Varieur Cadet | | Health Imaging | Artificial Intelligence
GE announced the formation of a new equity fund, the $250 million GE Healthymagination Fund, which will make investments in healthcare technology companies.

The fund will invest in companies globally that have diagnostic, IT and life sciences technologies aligned with GE’s Healthymagination initiative. The fund will also support healthcare companies developing “innovative and unique business models and services.”

The company said the fund’s formation is part of its $6 billion Healthymagination initiative. The fund will target three areas for investment:

  • Broad-based diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, imaging agents and other technologies for disease diagnosis.
  • Healthcare IT, including EMRs, clinical information systems, healthcare information exchanges and value-added data services.
  • Life Sciences, including tools for R&D in biopharmaceuticals and stem cells, and technologies for the manufacturing of biopharmaceuticals and vaccines.

GE said the fund will draw on capabilities from across GE Healthcare, GE Capital and GE Global Research.

Justine Varieur Cadet

Related Content

Most popular radiology video interviews on Health Imaging
RamSoft and Alpha Nodus partner to streamline imaging prior authorization processes
GE HealthCare launches new AI-enabled automated breast ultrasound system
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
What radiologists think about using ChatGPT and AI in breast imaging

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.